. Confirmation of quiescence and senescence and pathway analysis, related to Figure 1. (A) The experimental timeline for SILAC-based identification of the secretome of senescent cells. Cells (HCA2 human fibroblasts) were made quiescent by serum deprivation (0.2%) for 3 days, then incubated in serum free medium for 24 hours (quiescent CM). Cells were made senescent by ionizing radiation (IR; 10 Gy X-irradiation), incubated in complete medium (10% serum), with changes every 2-3 days, for 8 days, then incubated in serum free medium for 24 hours (senescent CM). (B) HCA2 cells were made quiescent or induced to senesce by IR. Three and 9 days later respectively, the cells were counted and re-seeded in complete medium, and stained for senescence-associated beta-galactosidase activity (SA-β-gal). (C) HCA2 cells were made quiescent or senescent, as described in (A). Three and 9 days later respectively, cells were counted and re-seeded in 0.2% serum (for quiescent cells) or complete medium (for both quiescent and senescent cells). The next day, cells were given BrdU for 24 h, fixed and immunostained for nuclear BrdU. **, p<0.01. Data reflect means of 3 experiments. 
Figure S2. Expression of hemostasis-related SASP genes in WI-38 human fibroblasts and human umbilical vascular endothelial cells (HUVEC), related to Figure 2. (A)
We induced senescence in WI-38 human fetal lung fibroblasts treated using DOXO and extracted RNA 9 d later, and analyzed for the indicated mRNAs by quantitative PCR. Bars reflect means of 3 experiments + SEM. * = p<0.05; *** = p<0.001.
(B)
We induced HUVECs to senesce via 10 Gy of IR or treated with mock irradiation, and extracted mRNA from both treatment groups 10 days later. We analyzed mRNA levels of hemostasis factors by quantitative PCR. mRNA levels for all groups were normalized to actin mRNA. All values of p<0.05 are indicated by * in the heat map. 
